These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 35092710)

  • 1. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
    Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
    J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
    Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
    Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
    Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
    J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
    Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tryptophan and its metabolites in renal allograft recipients].
    Myśliwiec P; Myśliwiec H; Pawlak D; Dadan J; Buczko W; Pawlak K
    Przegl Lek; 2009; 66(3):115-8. PubMed ID: 19689033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
    Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
    Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
    Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
    Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.